Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Bactiquant BACTIQ Nov 25, 2022 7.99 -0.13   
 Bang & Olufsen BO Nov 25, 2022 9.71 -0.87   
 BankNordik P/F BNORDIKCSE Nov 25, 2022 125.00 +1.21   
 Bavarian Nordic BAVA Nov 25, 2022 230.90 -2.08   
 BioPorto BIOPOR Nov 25, 2022 2.50 -0.20   
 Blue Vision A BLVISA Nov 25, 2022 0.80 +1.91   
 Boozt BOOZTDKK Nov 25, 2022 69.50 -2.80   
 Brain+ BRAINP Nov 25, 2022 2.20 0.00   
 Brd. Klee B KLEEB Nov 25, 2022 4 840.00 +19.21   
 Brdr. A & O Johansen Pref B AOJB Nov 25, 2022 84.82 +1.08   
 Brdr.Hartmann HART Nov 25, 2022 284.00 +1.79   
 Brøndbyernes IF Fodbold BIF Nov 25, 2022 0.54 +1.31   
 Carlsberg A CARLA Nov 25, 2022 1 185.00 +0.85   
 Carlsberg B CARLB Nov 25, 2022 901.80 -0.40   
 cBrain CBRAIN Nov 25, 2022 176.90 -1.39   
 Cemat CEMAT Nov 25, 2022 0.72 +4.03   
 ChemoMetec CHEMM Nov 25, 2022 844.00 -1.52   
 Chr. Hansen Holding CHR Nov 25, 2022 438.30 -1.48   
 Coloplast B COLOB Nov 25, 2022 878.00 -0.05   
 Columbus COLUM Nov 25, 2022 6.66 -3.20   
 Conferize CONFRZ Nov 25, 2022 0.06 -1.79   
 Copenhagen Capital CPHCAPST Nov 25, 2022 6.25 0.00   
 Copenhagen Capital Pref CPHCAPPREF Nov 25, 2022 2.08 0.00   
 Copyright Agent COPY Nov 25, 2022 1.14 0.00   
 D/S Norden DNORD Nov 25, 2022 354.00 +2.49   
 Danish Aerospace Company DAC Nov 25, 2022 3.98 -2.69   
 Danske Andelskassers Bank DAB Nov 25, 2022 10.25 +2.50   
 Danske Bank DANSKE Nov 25, 2022 127.40 +0.75   
 Dantax DANT Nov 25, 2022 376.00 -1.57   
 Dataproces Group DATA Nov 25, 2022 2.20 +0.46   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+